Regulatory approval in Canada falls under Health Canada, which oversees both pharmaceutical and compounded preparations
These therapies are driven by public healthcare coverage, increased access to prescription medicines, and increased awareness of weight management
Limited material availability necessitated that the off-target analysis and 5-RACE assay be performed with one sample per group
We used the following keywords: GLP-1, GLP-1 receptor agonist, exenatide, liraglutide, lixisenatide, semaglutide, albiglutide, dulaglutide, efpeglenatide, coronary artery disease, coronary atherosclerosis, endothelial dysfunction, inflammation, body weight, blood pressure, lipids, aggregation, coagulation, coronary vasospasm, coronary vasodilation, coronary microvascular, acute coronary syndrome, myocardial infarction, unstable angina, stable angina, chronic coronary syndrome, vasospastic angina, microvascular angina, coronary revascularization